SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-23-056298
Filing Date
2023-03-01
Accepted
2023-03-01 16:06:03
Documents
5
Period of Report
2023-04-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A d456007ddef14a.htm DEF 14A 193179
2 GRAPHIC g456007g54q26.jpg GRAPHIC 44672
3 GRAPHIC g456007g54q27.jpg GRAPHIC 27096
4 GRAPHIC g456007g54q28.jpg GRAPHIC 182921
5 GRAPHIC g456007g54q29.jpg GRAPHIC 155118
  Complete submission text file 0001193125-23-056298.txt   751292
Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36352 | Film No.: 23693444
SIC: 2834 Pharmaceutical Preparations